Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma

Author:

Kraal Kathelijne CJM12,van Dalen Elvira C1,Tytgat Godelieve AM1,Van Eck-Smit Berthe LF3

Affiliation:

1. Emma Children's Hospital/Academic Medical Center; Department of Paediatric Oncology; PO Box 22660 Amsterdam Netherlands 1100 DD

2. Princess Maxima Center for Pediatric Oncology; Postbus 85090 Room KE 01.129.2 Utrecht Netherlands 3508 AB

3. Academic Medical Center; Nuclear Medicine; P.O Box 9 Amsterdam Netherlands 2200 DD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference102 articles.

1. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age;Kraker;European Journal of Cancer,2008

2. Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan;Kraal;Pediatric Blood and Cancer,2015

3. Bleeker G Schoot R Caron H van Eck B de Kraker J Tytgat G 20 years of 131iodine-metaiodobenzylguanidine (131I-MIBG) therapy upfront: a retrospective analysis of acute toxicity Pediatric Blood and Cancer 2009 736

4. Toxicity of upfront 131I-meta-iodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis;Bleeker;European Journal of Nuclear Medical Molecular Imaging,2013

5. Thyroidal uptake and radiation dose after repetitive I-131-MIBG treatments: influence of potassium iodide for thyroid blocking;Brans;Medical and Pediatric Oncology,2002

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3